Literature DB >> 18284396

Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate.

S R Wiegell1, J Skiveren, P A Philipsen, H C Wulf.   

Abstract

BACKGROUND: Pain during photodynamic therapy (PDT) is a considerable problem that needs to be studied to improve this otherwise attractive treatment of skin diseases.
OBJECTIVES: To compare pain during PDT using two different fluence rates, and also to evaluate the association between pain and protoporphyrin IX (PpIX) fluorescence, lesion type, lesion preparation and lesion localization.
METHODS: Twenty-six patients with actinic keratoses (AKs) in different localizations and 34 patients with facial acne vulgaris were treated with methyl aminolaevulinate-PDT. Patients with acne were illuminated using two different fluence rates. Pain score during PDT and PpIX fluorescence prior to illumination were measured.
RESULTS: The study showed that pain during illumination was associated with the PpIX fluorescence in the treatment area (P = 0.0003, R(2) = 0.31). When using a fluence rate of 34 mW cm(-2) patients with acne had a pain score of 6 [interquartile range (IQR) 5-7] compared with 8 (IQR 6-10) when using a fluence rate of 68 mW cm(-2) (P = 0.018). After correcting the pain score for PpIX fluorescence no differences in pain scores were found between first and second acne treatment, locations of AK lesions or between the two types of lesions.
CONCLUSIONS: Pain during PDT was correlated with the PpIX fluorescence in the treatment area prior to illumination. Pain was reduced using a lower fluence rate during PDT of acne.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284396     DOI: 10.1111/j.1365-2133.2008.08451.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer.

Authors:  Nathalie C Zeitouni; Ulas Sunar; Daniel J Rohrbach; Anne D Paquette; David A Bellnier; Yi Shi; Gregory Wilding; Thomas H Foster; Barbara W Henderson
Journal:  Dermatol Surg       Date:  2014-12       Impact factor: 3.398

2.  Advances in antimicrobial photodynamic inactivation at the nanoscale.

Authors:  Nasim Kashef; Ying-Ying Huang; Michael R Hamblin
Journal:  Nanophotonics       Date:  2017-08-01       Impact factor: 8.449

Review 3.  Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy.

Authors:  M Lam; A H Hsia; Y Liu; M Guo; A R Swick; J C Berlin; T S McCormick; M E Kenney; N L Oleinick; K D Cooper; E D Baron
Journal:  Clin Exp Dermatol       Date:  2011-05-30       Impact factor: 3.470

Review 4.  Pain associated with aminolevulinic acid-photodynamic therapy of skin disease.

Authors:  Christine B Warren; Laszlo J Karai; Allison Vidimos; Edward V Maytin
Journal:  J Am Acad Dermatol       Date:  2009-12       Impact factor: 11.527

5.  In-office Painless Aminolevulinic Acid Photodynamic Therapy: A Proof of Concept Study and Clinical Experience in More Than 100 Patients.

Authors:  George M Martin
Journal:  J Clin Aesthet Dermatol       Date:  2016-02

Review 6.  Early and Late Onset Side Effects of Photodynamic Therapy.

Authors:  Francesco Borgia; Roberta Giuffrida; Emanuela Caradonna; Mario Vaccaro; Fabrizio Guarneri; Serafinella P Cannavò
Journal:  Biomedicines       Date:  2018-01-29

Review 7.  Measuring Daylight: A Review of Dosimetry in Daylight Photodynamic Therapy.

Authors:  Paul O'Mahoney; Marina Khazova; Ewan Eadie; Sally Ibbotson
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.